Cipher Pharmaceuticals Inc. (CPHRF)
OTCMKTS · Delayed Price · Currency is USD
9.45
-0.18 (-1.87%)
Nov 13, 2025, 4:00 PM EST
Cipher Pharmaceuticals Market Cap
Cipher Pharmaceuticals has a market cap or net worth of $240.61 million as of November 14, 2025. Its market cap has decreased by -15.84% in one year.
Market Cap
240.61M
Enterprise Value
245.55M
Revenue
50.06M
Ranking
n/a
PE Ratio
13.86
Stock Price
$9.45
Market Cap Chart
Since February 25, 2004, Cipher Pharmaceuticals's market cap has increased from 58.00M to 240.61M, an increase of 314.88%. That is a compound annual growth rate of 6.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 240.61M | -5.52% |
| Dec 31, 2024 | 254.68M | 152.73% |
| Dec 29, 2023 | 100.77M | 41.37% |
| Dec 30, 2022 | 71.28M | 94.22% |
| Dec 31, 2021 | 36.70M | 86.01% |
| Dec 31, 2020 | 19.73M | -36.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 836.20M |
| Elite Pharmaceuticals | 716.54M |
| Glass House Brands | 604.34M |
| American Oncology Network | 372.31M |
| Northwest Biotherapeutics | 367.30M |
| Silence Therapeutics | 317.88M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 304.26M |